- Home
- DYN vs TRMK Comparison
DYN vs TRMK Comparison
Compare DYN & TRMK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- TRMK
- Stock Information
- Founded
- DYN 1984
- TRMK 1889
- Country
- DYN United States
- TRMK United States
- Employees
- DYN N/A
- TRMK N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- TRMK Major Banks
- Sector
- DYN Health Care
- TRMK Finance
- Exchange
- DYN Nasdaq
- TRMK Nasdaq
- Market Cap
- DYN 2.6B
- TRMK 2.2B
- IPO Year
- DYN 2020
- TRMK 1987
- Fundamental
- Price
- DYN $25.95
- TRMK $37.31
- Analyst Decision
- DYN Strong Buy
- TRMK Hold
- Analyst Count
- DYN 11
- TRMK 5
- Target Price
- DYN $51.18
- TRMK $34.60
- AVG Volume (30 Days)
- DYN 836.3K
- TRMK 271.2K
- Earning Date
- DYN 11-12-2024
- TRMK 01-21-2025
- Dividend Yield
- DYN N/A
- TRMK 2.45%
- EPS Growth
- DYN N/A
- TRMK 111.96
- EPS
- DYN N/A
- TRMK 3.30
- Revenue
- DYN N/A
- TRMK $555,586,000.00
- Revenue This Year
- DYN N/A
- TRMK N/A
- Revenue Next Year
- DYN N/A
- TRMK $4.04
- P/E Ratio
- DYN N/A
- TRMK $11.24
- Revenue Growth
- DYN N/A
- TRMK N/A
- 52 Week Low
- DYN $11.66
- TRMK $25.24
- 52 Week High
- DYN $47.45
- TRMK $40.73
- Technical
- Relative Strength Index (RSI)
- DYN 38.55
- TRMK 46.75
- Support Level
- DYN $25.27
- TRMK $36.99
- Resistance Level
- DYN $28.96
- TRMK $38.15
- Average True Range (ATR)
- DYN 1.41
- TRMK 0.95
- MACD
- DYN -0.23
- TRMK -0.30
- Stochastic Oscillator
- DYN 14.25
- TRMK 26.35
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.
About TRMK Trustmark Corporation
Trustmark Corp is a s a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee and Texas. Its principal products and services include, Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services and others. The company is managed along three operating segments; General Banking, Wealth Management and Insurance. The General Banking segment which generates the majority of the revenue provides all traditional banking products and services, including loans, deposits and also consists of internal operations.